Driving research, providing support and improving outcomes for rare disease patients and their families



New Curated Osteosarcoma Clinical Trial Database

New Curated Osteosarcoma Clinical Trial Database

We are delighted to launch our curated osteosarcoma clinical trial database. Our clinical trial database was designed so that patients have the tools and information to explore new treatment options and make decisions that are right for them. Each trial has been...
2021: A year in review

2021: A year in review

A week is a long time in politics, 3 months is a long time when we are cut off from society in covid times, and a year is…. just about enough time to reinvigorate a charity and embark on a new era it seems.      In January 2021, I had the great honour to be...
ESMO Sarcoma & GIST 2022 Symposium Report

ESMO Sarcoma & GIST 2022 Symposium Report

The European Society of Medical Oncology (ESMO) Sarcoma & GIST Symposium 2022 took place from 31 January to 2 February 2022. The Myrovlytis Trust were delighted to attend the symposium and witness researchers from across the globe coming together to share their...
Science Communication Training Course

Science Communication Training Course

We are delighted to announce a fully funded science communication training course for PhD students working in BHD or osteosarcoma. The course will provide students with the tools to present and discuss their work with a variety of audiences. We see this as a key skill...
Our Work Experience at the Myrovlytis Trust

Our Work Experience at the Myrovlytis Trust

Guest blog post by Mariné, Leila and Sofia. Our work experience team consisted of two psychology undergraduate students (Mariné and Leila) and a school student studying art and design (Sofia). We are grateful to have had the opportunity to work with the Myrovlytis...